1주차| 보건,의료 _ 김해린

[김해린]

원문: https://www.who.int/news-room/speeches/item/who-director-general-s-speech-at-uhc-high-level-forum-dinner-event-5-december-2025?utm_source=chatgpt.com

누가: WHO Director-General (세계보건기구(WHO) 사무총장)

언제: 2025년 12월 5일

어디서: UHC High-Level Forum 만찬 행사

[glossary]

1	noncommunicable diseases	비감염성질환
2	antimicrobial resistance	항균제 내성	항생제뿐만 아니라 항바이러스제, 항진균제 등 모든 종류의 항균 약물에 대해 내성을 갖는 더 넓은 의미의 용어
3	universal health coverage (UHC)	보편적 건강보장	모든 사람이 필요한 보건의료 서비스를 경제적 부담 없이 이용할 수 있도록 보장하는 것
4	health sovereignty	보건 주권
5	pooled procurement	공동 조달	여러 국가나 기관이 수요를 하나로 묶어 의약품·백신·의료기기 등을 함께 조달하는 방식

[words:442]

I have been asked to discuss the challenges that we are facing in global health, and there are many, but I would like to begin by reflecting on our achievements.

We can often be so focused on the challenges that we forget just how far we have come.

Over the past 25 years, we have seen incredible achievements in global health.

Over 90 million deaths have been averted due to vaccination;

Maternal mortality has dropped by 40%, under-five mortality has decreased by more than half and stillbirths by more than a third;

Deaths from HIV have dropped by two-thirds, deaths from malaria by one-third, deaths from tobacco use by 40%.

These incredible results are thanks to the collective efforts of countries and communities, supported by an array of partners, donors, civil society, researchers and the private sector.

But as we all know, these gains – and the opportunity to drive further progress – are at risk.

We face the challenges of conflict and insecurity, outbreaks, inequality, the growing burden of noncommunicable diseases and mental health disorders, the steady march of antimicrobial resistance, the overshadowing threat of climate change, and the ever-present danger of pandemics.

And although we have seen significant advances since 2000 towards universal health coverage, progress on both service coverage and financial protection now appears to have stalled.

Severe cuts to international aid this year have also caused severe disruptions to health services in many countries.

But I am confident that in the crisis lies an opportunity – an opportunity to leave behind the era of aid dependency and embrace a new era of health sovereignty, based on domestic resources.

Likewise, although WHO and global health institutions in general are facing a significant reduction in funding, this is also an opportunity for us to recalibrate so we can support countries to make that transition to domestic funding for their health systems.

We must also recognize that the challenges we face now are different to those we faced when the global health architecture was built in the early years of this century.

Of course, many countries will continue to need bilateral and multilateral support. But we must be clear that external funds are to complement and not to replace domestic resources.

WHO is supporting countries to maintain essential health services, while making the transition to stronger, domestically and publicly-financed health systems.

In the short-term, WHO is supporting countries to develop affordable essential health benefit packages;

To introduce or increase health taxes on tobacco, alcohol and sugary drinks;

To strengthen domestic manufacturing, pooled procurement and other initiatives.

In the longer term, countries can strengthen risk-sharing mechanisms to improve financial protection, including through publicly-financed health insurance.